Pharmaceutical industry criticizes the drug pricing plan Trump will sign
Source: ABC News/AP
May 12, 2025, 7:28 AM
WASHINGTON -- President Donald Trump's plan to change the pricing model for some medications is already facing fierce criticism from the pharmaceutical industry before he's even signed the executive order set for Monday that, if implemented, could lower the cost of some drugs. Trump has promised that his plan which is likely to tie the price of medications covered by Medicare and administered in a doctors office to the lowest price paid by other countries will significantly lower drug costs.
I will be instituting a MOST FAVORED NATIONS POLICY whereby the United States will pay the same price as the Nation that pays the lowest price anywhere in the World, the Republican president posted on social media on Sunday, pledging to sign the order on Monday morning at the White House. But the nation's leading pharmaceutical lobby on Sunday pushed back, calling it a bad deal for American patients.
Drugmakers have long argued that any threats to their profits could impact the research they do to develop new drugs. Importing foreign prices will cut billions of dollars from Medicare with no guarantee that it helps patients or improves their access to medicines, Stephen J. Ubl, the president and CEO of PhRMA, said in a statement. It jeopardizes the hundreds of billions our member companies are planning to invest in America, making us more reliant on China for innovative medicines.
Trump's so-called most favored nation approach to Medicare drug pricing has been controversial since he first tried to implement it during his first term. He signed a similar executive order in the final weeks of his presidency, but a court order later blocked the rule from going into effect under President Joe Biden's administration. The pharmaceutical industry has argued that Trumps 2020 attempt would give foreign governments the upper hand in deciding the value of medicines in the U.S.
Read more: https://abcnews.go.com/Health/wireStory/pharmaceutical-industry-criticizes-drug-pricing-plan-trump-hell-121705643
He just signed it and put a deadline on it.


Stargazer99
(3,195 posts)See how we the public pay for research and business says they need profit to do research they have the taxpayer dumbed down...no critical thinking allowed here
LiberalArkie
(18,161 posts)GOP spoiled that approach to doing things back in Jimmy Carters days.
Tarzanrock
(830 posts)will soon cost $12.00 under this new plan. Are we "great," yet? This is just another "soon to be failed" bonehead idea from the very stable genius -- just like the Turd's failed economic tariffs policies. Your pocketbook and your bank account will soon tell you just how "great" we have become under the Turd's stewardship.
Journeyman
(15,324 posts)and what better way than cynically manipulating a hugely popular idea, one which can later be reversed and blamed on the influence of "the deep state" or the machinations of "the government" or "politics as usual."
ProfessorGAC
(72,568 posts)...they could absorb the price cuts & still fund most research if they quit advertising their products 3 times per hour on 50 different channels.
Maybe the doctors should be making the recommendations & not fielding requests.
Jacson6
(1,222 posts)They mean that they won't get their pay us money or die dollars from the federal government and Medicare patients. They are F...ing predators.
Tarzanrock
(830 posts)that they have slashed the Federal Trade Commission (FTC) and regulatory prosecutors at the Department of Justice which investigates things like Medicare Fraud and Medicaid Fraud by the Pharmaceutical/Insurance Oligarchies as well as the Pharmacies and the Pharmacy Benefit Managers. Thus,
there is no more effective "regulation" of these thieving entities stealing taxpayer funded Medicare/Medicaid monies. It's the "Golden Age" of Theft in America, thanks to the criminal Turd.
LudwigPastorius
(12,394 posts)Pay him and it will go away.
He's practically got his hand out saying "pay me!"